141 related articles for article (PubMed ID: 9236675)
1. Elevated serum levels of neopterin in adult patients with polymyositis/dermatomyositis.
Samsonov MY; Nassonov EL; Tilz GP; Geht BM; Demel U; Gurkina GT; Shtutman VZ; Guseva AG; Wachter H; Fuchs D
Br J Rheumatol; 1997 Jun; 36(6):656-60. PubMed ID: 9236675
[TBL] [Abstract][Full Text] [Related]
2. Elevation of serum soluble tumour necrosis factor receptors in patients with polymyositis and dermatomyositis.
Shimizu T; Tomita Y; Son K; Nishinarita S; Sawada S; Horie T
Clin Rheumatol; 2000; 19(5):352-9. PubMed ID: 11055823
[TBL] [Abstract][Full Text] [Related]
3. Serum concentrations of neopterin, soluble interleukin 2 receptor, and soluble tumor necrosis factor receptor in Wegener's granulomatosis.
Nassonov EL; Samsonov MY; Tilz GP; Beketova TV; Semenkova EN; Baranov A; Wachter H; Fuchs D
J Rheumatol; 1997 Apr; 24(4):666-70. PubMed ID: 9101499
[TBL] [Abstract][Full Text] [Related]
4. Elevated serum levels of interleukin-1 receptor antagonist in polymyositis/dermatomyositis. A biologic marker of disease activity with a possible role in the lack of acute-phase protein response.
Gabay C; Gay-Croisier F; Roux-Lombard P; Meyer O; Maineti C; Guerne PA; Vischer T; Dayer JM
Arthritis Rheum; 1994 Dec; 37(12):1744-51. PubMed ID: 7986220
[TBL] [Abstract][Full Text] [Related]
5. Serum concentration of interleukin 15, interleukin 2 receptor and TNF receptor in patients with polymyositis and dermatomyositis: correlation to disease activity.
Mielnik P; Chwalinska-Sadowska H; Wiesik-Szewczyk E; Maslinski W; Olesinska M
Rheumatol Int; 2012 Mar; 32(3):639-43. PubMed ID: 21132303
[TBL] [Abstract][Full Text] [Related]
6. Soluble IL-2 Receptor in Dermatomyositis: Its Associations with Skin Ulcers and Disease Activity.
He L; Shu X; Liu X; Ge Y; Li S; Lu X; Wang G
Mediators Inflamm; 2020; 2020():6243019. PubMed ID: 32774147
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of soluble TNF alpha receptor type I and the severity of systemic sclerosis.
Majewski S; Wojas-Pelc A; Malejczyk M; Szymanska E; Jablonska S
Acta Derm Venereol; 1999 May; 79(3):207-10. PubMed ID: 10384918
[TBL] [Abstract][Full Text] [Related]
8. Elevated Serum Levels of Soluble CD163 in Polymyositis and Dermatomyositis: Associated with Macrophage Infiltration in Muscle Tissue.
Peng QL; Zhang YL; Shu XM; Yang HB; Zhang L; Chen F; Lu X; Wang GC
J Rheumatol; 2015 Jun; 42(6):979-87. PubMed ID: 25877505
[TBL] [Abstract][Full Text] [Related]
9. Serum neopterin as well as ferritin, soluble interleukin-2 receptor, KL-6 and anti-MDA5 antibody titer provide markers of the response to therapy in patients with interstitial lung disease complicating anti-MDA5 antibody-positive dermatomyositis.
Nishioka A; Tsunoda S; Abe T; Yoshikawa T; Takata M; Kitano M; Matsui K; Nakashima R; Hosono Y; Ohmura K; Mimori T; Sano H
Mod Rheumatol; 2019 Sep; 29(5):814-820. PubMed ID: 30449228
[No Abstract] [Full Text] [Related]
10. Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer.
Gadducci A; Ferdeghini M; Malagnino G; Prontera C; Fanucchi A; Annicchiarico C; Bianchi R; Fioretti P; Facchini V
Gynecol Oncol; 1994 Mar; 52(3):386-91. PubMed ID: 8157196
[TBL] [Abstract][Full Text] [Related]
11. Serum-soluble receptors for tumor necrosis factor-alpha and interleukin-2, and neopterin in acute rheumatic fever.
Samsonov MY; Tilz GP; Pisklakov VP; Reibnegger G; Nassonov EL; Nassonova VA; Wachter H; Fuchs D
Clin Immunol Immunopathol; 1995 Jan; 74(1):31-4. PubMed ID: 7994924
[TBL] [Abstract][Full Text] [Related]
12. High dose intravenous immunoglobulin (IVIG) in dermatomyositis: clinical responses and effect on sIL-2R levels.
Göttfried I; Seeber A; Anegg B; Rieger A; Stingl G; Volc-Platzer B
Eur J Dermatol; 2000; 10(1):29-35. PubMed ID: 10694294
[TBL] [Abstract][Full Text] [Related]
13. Urine neopterin as a parameter of disease activity in patients with systemic lupus erythematosus: comparisons with serum sIL-2R and antibodies to dsDNA, erythrocyte sedimentation rate, and plasma C3, C4, and C3 degradation products.
Lim KL; Jones AC; Brown NS; Powell RJ
Ann Rheum Dis; 1993 Jun; 52(6):429-35. PubMed ID: 8323394
[TBL] [Abstract][Full Text] [Related]
14. Increase in soluble interleukin-2 receptor and neopterin serum levels during immunotherapy of cancer with interleukin-2.
Lissoni P; Tisi E; Brivio F; Barni S; Rovelli F; Perego M; Tancini G
Eur J Cancer; 1991; 27(8):1014-6. PubMed ID: 1832885
[TBL] [Abstract][Full Text] [Related]
15. Increased serum soluble interleukin-2 receptor levels in dermatomyositis are associated with Th17/Treg immune imbalance.
Xie Y; Zhang T; Su R; Liu L; Jiang L; Xue H; Gao C; Li X; Wang C
Clin Exp Med; 2023 Nov; 23(7):3605-3617. PubMed ID: 37528249
[TBL] [Abstract][Full Text] [Related]
16. Increased serum levels of soluble vascular cell adhesion molecule-1 and soluble E-selectin in patients with polymyositis/dermatomyositis.
Kubo M; Ihn H; Yamane K; Yazawa N; Kikuchi K; Soma Y; Tamaki K
Br J Dermatol; 2000 Aug; 143(2):392-8. PubMed ID: 10951151
[TBL] [Abstract][Full Text] [Related]
17. Abnormal IL-1 receptor antagonist production in patients with polymyositis and dermatomyositis.
Son K; Tomita Y; Shimizu T; Nishinarita S; Sawada S; Horie T
Intern Med; 2000 Feb; 39(2):128-35. PubMed ID: 10732829
[TBL] [Abstract][Full Text] [Related]
18. [Neopterin: marker of cellular immunity activation in idiopathic inflammatory myopathy].
Nasonov EL; Samsonov MI; Shtutman VZ; Gekht BM; Gurkina GT; Tilz GP; Guseva NG; Fuchs D; Wachter H
Klin Med (Mosk); 1997; 75(2):47-51. PubMed ID: 9157218
[No Abstract] [Full Text] [Related]
19. Effects of granulocyte-macrophage colony stimulating factor on soluble interleukin-2 receptor serum levels and their relation to neopterin and tumor necrosis factor-alpha in cancer patients.
Crispino S; Lissoni P; Ardizzoia A; Rovelli F; Perego MS; Grassi MG; Barni S; Pittalis S; Tancini G
J Biol Regul Homeost Agents; 1993; 7(3):92-4. PubMed ID: 8135145
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum levels of manganese superoxide dismutase in polymyositis and dermatomyositis.
Mokuno K; Kiyosawa K; Honda H; Hirose Y; Murayama T; Yoneyama S; Kato K
Neurology; 1996 May; 46(5):1445-7. PubMed ID: 8628497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
